IO Biotech is a clinical stage biotech company developing disruptive immune modulating anti-cancer therapies. We are focused on the development of immunological treatment of cancer with a research profile based on successful R&D discoveries, translated into numerous clinical trials.
IO Biotech has achieved a proven track record of progressing pre-clinical and clinical compounds:
Two lead anti-cancer therapies targeting I...
IO Biotech is a clinical stage biotech company developing disruptive immune modulating anti-cancer therapies. We are focused on the development of immunological treatment of cancer with a research profile based on successful R&D discoveries, translated into numerous clinical trials.
IO Biotech has achieved a proven track record of progressing pre-clinical and clinical compounds:
Two lead anti-cancer therapies targeting IDO and PD-L1 are in clinical development
Several compounds finalizing the preclinical phase
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.